The previous page is sending you to http://globenewswire.com/news-release/2015/07/10/751271/0/en/Novo-Nordisk-successfully-completes-first-phase-3a-trial-with-semaglutide-in-people-with-type-2-diabetes.html.

 If you do not want to visit that page, you can return to the previous page.